BD Neopak™ XtraFlow™ Glass Prefillable Syringe for Biologic Delivery
Products
Information
Needle length and needle wall diameter are key parameters influencing injection force for a given injection time and solution viscosity. Reducing the injection force required to deliver solutions by manual injection is a parameter influencing patient preference, especially when high viscosities are injected. BD Medical - Pharmaceutical Systems is launching BD Neopak™ XtraFlow™* – a prefillable, glass-based syringe solution featuring an 8 mm needle with thinner wall cannula technology. This solution enables the transition from 12.7mm needle length towards shorter, 8mm needles and provides reduced pressure and enhances flow with thinner wall needle technology. BD Neopak™ XtraFlow™ PFS can provide an improved solution for subcutaneous drug delivery for both end-users and for pharmaceutical companies.
BD offers a broad portfolio of prefillable solutions specifically designed for biopharmaceuticals and chronic disease treatments. Our scientific expertise and breakthrough technologies backed by innovative global manufacturing capabilities enable these syringes while lowering total cost of ownership for your sensitive drugs.
https://drugdeliverysystems.bd.com/contact-us
* BD Neopak™ XtraFlow™ is a product in development; some statements are subject to a variety of risks and uncertainties.
BD, the BD Logo, BD Neopak and XtraFlow are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved.
Available In
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Categories
Primary PackagingDrug Delivery SystemsSyringes/prefilled syringes
